Page last updated: 2024-08-24

squaric acid dibutyl ester and Verruca

squaric acid dibutyl ester has been researched along with Verruca in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's4 (33.33)18.2507
2000's5 (41.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, HY; Choi, YW; Kim, SH; Lee, SW; Oh, MK; Park, HJ; Shin, MS1
Burkhart, CN; Dasher, DA; Morrell, DS1
Hama, N; Hamasaki, Y; Hatamochi, A; Hayashi, S; Namikawa, H; Sotome, A; Yamazaki, S1
Silverberg, JI; Silverberg, NB1
Diaferio, A; Lopalco, PL; Mastrolonardo, M1
Claudy, AL; Roche, H1
Iijima, S; Otsuka, F1
Fowler, JF; Hodge, SJ; Tobin, GR1
Buckley, DA; du Vivier, AW1
Lee, AN; Mallory, SB1
Dall'Oglio, F; Micali, G; Nasca, MR; Pulvirenti, N; Tedeschi, A1
Lim, JK; Mancini, AJ; Paller, AS; Silverberg, NB1

Reviews

2 review(s) available for squaric acid dibutyl ester and Verruca

ArticleYear
Immunotherapy for childhood warts.
    Pediatric annals, 2009, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens; Child; Child, Preschool; Cimetidine; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Histamine H2 Antagonists; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Irritants; Treatment Outcome; Warts

2009
Topical immunotherapy in dermatology.
    International journal of clinical practice, 1999, Volume: 53, Issue:2

    Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Decision Making; Dinitrochlorobenzene; Humans; Immunotherapy; Warts

1999

Trials

1 trial(s) available for squaric acid dibutyl ester and Verruca

ArticleYear
Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience.
    Archives of dermatology, 2000, Volume: 136, Issue:4

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Child; Child, Preschool; Cyclobutanes; Humans; Middle Aged; Treatment Outcome; Warts

2000

Other Studies

9 other study(ies) available for squaric acid dibutyl ester and Verruca

ArticleYear
Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
    Clinical and experimental dermatology, 2013, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Case-Control Studies; Cyclobutanes; Cytokines; Female; Humans; Immunotherapy; Interferon-gamma; Interleukins; Male; Middle Aged; T-Lymphocytes; Tumor Necrosis Factor-alpha; Warts; Young Adult

2013
Usefulness of topical immunotherapy with squaric acid dibutylester for refractory common warts on the face and neck.
    The Journal of dermatology, 2009, Volume: 36, Issue:12

    Topics: Administration, Topical; Adult; Allergens; Cyclobutanes; Face; Humans; Immunotherapy; Male; Middle Aged; Neck; Warts

2009
Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Cantharidin; Caustics; Child; Child, Preschool; Confidence Intervals; Cyclobutanes; Drug Therapy, Combination; Female; Humans; Infant; Irritants; Male; Proportional Hazards Models; Retrospective Studies; Statistics, Nonparametric; Trichloroacetic Acid; Warts; Young Adult

2012
Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity.
    Contact dermatitis, 2002, Volume: 47, Issue:4

    Topics: Administration, Topical; Alopecia; Cohort Studies; Cyclobutanes; Dermatitis, Allergic Contact; Desensitization, Immunologic; Female; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Immunotherapy; Male; Probability; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Warts

2002
[Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
    Annales de dermatologie et de venereologie, 1981, Volume: 108, Issue:10

    Topics: Adolescent; Adult; Child; Cyclobutanes; Humans; Immunotherapy; Middle Aged; Recurrence; Warts

1981
Contact immunotherapy with squaric acid dibutylester for warts [corrected].
    Dermatology (Basel, Switzerland), 1993, Volume: 187, Issue:2

    Topics: Administration, Cutaneous; Adult; Allergens; Child; Child, Preschool; Combined Modality Therapy; Cryosurgery; Cyclobutanes; Dermatitis, Contact; Desensitization, Immunologic; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Treatment Outcome; Warts

1993
Persistent allergic contact dermatitis from squaric acid dibutyl ester.
    Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:2 Pt 1

    Topics: Adult; Allergens; Chronic Disease; Cyclobutanes; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Skin Diseases; Warts

1993
Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
    Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Allergens; Child; Child, Preschool; Cyclobutanes; Female; Humans; Immunotherapy; Infant; Male; Recurrence; Warts

1999
Squaric acid immunotherapy for warts in children.
    Journal of the American Academy of Dermatology, 2000, Volume: 42, Issue:5 Pt 1

    Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Cyclobutanes; Female; Humans; Immunotherapy; Male; Papillomaviridae; Papillomavirus Infections; Retrospective Studies; Tumor Virus Infections; Warts

2000